시장보고서

상품코드

1750882

초음파 내시경 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Endoscopic Ultrasound Market Size, Share & Trends Analysis Report By Product (Needle, Endoscope), By Application (Gastrointestinal Cancer, Lung Cancer), By End Use (ASCs, Hospitals), By Region, And Segment Forecasts, 2025 - 2030

발행일: 2025년 05월 | 리서치사:

Grand View Research | 페이지 정보: 영문 130 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

초음파 내시경 시장의 성장과 동향 :

Grand View Research, Inc의 최신 보고서에 따르면 세계의 초음파 내시경 시장 규모는 2025-2030년 연평균 6.85%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 22억 7,000만 달러에 달할 것으로 예측됩니다.

대장암 및 직장암과 같은 다양한 만성질환의 유병률 증가, 급속한 기술 발전, 의료비 지출 증가, 노인 인구 증가 등이 시장 성장의 주요 요인으로 작용하고 있습니다. 다양한 전략적 구상을 통해 다양한 주요 제조업체들이 개선된 내시경 시스템 및 고급 초음파 프로세서 설계와 같은 초음파 내시경(EUS) 기술의 발전은 시장 성장을 더욱 촉진할 것입니다.

예를 들어 2023년 2월 FUJIFILM India Private Limited는 소형 초음파 프로브 시스템 PB2020-M2를 출시했습니다. 이 초음파 프로브는 보다 효과적인 평가를 위해 폐 말초 병변의 실제 초음파 이미징을 가능하게 합니다. 이 소형 경량 장비는 고품질 초음파 영상을 제공합니다. 또한 주요 기업은 내시경 솔루션 포트폴리오를 확장하기 위해 신제품을 출시하고 있습니다. 예를 들어 2023년 1월 FUJIFILM India Private Limited는 ClutchCutter와 FushKnife를 출시했습니다. 이러한 요인들은 예측 기간 중 시장 성장을 가속할 것으로 예측됩니다.

EUS와 같은 최소침습 수술은 기존 수술에 비해 회복 속도가 빠르고 수술 후 합병증을 최소화할 수 있으므로 수요 증가가 시장 성장을 촉진할 것으로 예측됩니다. 또한 EUS 기술 연구개발에서 의료기기 기업과 의료기관의 협력은 시장 성장을 더욱 촉진할 것입니다. 예를 들어 2023년 9월, 후지필름 인도는 Yashoda Group of Hospitals와 전략적 제휴를 맺었습니다. 이 전략적 제휴는 전국 환자 치료 수준을 향상시키기 위해 야쇼다 그룹의 모든 거점과 협력하여 교육 및 임상 연구 프로젝트를 지원합니다.

초음파 내시경 시장 보고서 하이라이트

내시경 부문은 2024년 약 33.84%의 최대 매출 점유율로 시장을 선도했습니다.
용도별로는 폐암 분야가 2024년 42.18%의 매출 점유율로 시장을 선도했습니다.
병원 부문은 2024년 가장 큰 시장 점유율을 차지했습니다. 이러한 확대는 최소침습적 시술에 대한 유리한 의료비 상환, 발달된 의료 인프라, 숙련되고 자격을 갖춘 내시경 의사 증가에 기인합니다.
북미 초음파 내시경 산업은 2024년 31.0%의 매출 점유율을 차지하며 세계 시장을 독점하고 있습니다.

지역별 시장 점유율 분석, 2024년 및 2030년
지역별 시장 대시보드
시장 규모, 예측, 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

기업/경쟁 분류
전략 지도제작
기업 시장 현황 분석, 2024년
기업 개요/리스트
- Boston Scientific Corporation
- Medtronic
- ConMed
- Olympus Corporation
- Steris
- SonoScape Medical Corp.
- PENTEX Medical
- FUJIFILM India Private Limited
- Cook Medical
- Medi-Globe GmbH

KSA 25.06.26

Endoscopic Ultrasound Market Growth & Trends:

The global endoscopic ultrasound market size is anticipated to reach USD 2.27 billion by 2030, registering a CAGR of 6.85% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of various chronic disorders, such as colorectal cancer, and rectum cancer, rapid technological advancements, rising healthcare spending, and a rise in the geriatric population, are key contributors to the market growth. Advancements in endoscopic ultrasound (EUS) technology, such as improved endoscope systems and advanced ultrasound processor designs by various key manufacturers through different strategic initiatives, will further drive market growth.

For instance, in February 2023, FUJIFILM India Private Limited introduced the compact ultrasonic probe system PB2020-M2. This ultrasonic probe enables actual ultrasound imaging of peripheral lung lesions for a more effective evaluation. This compact, lightweight device offers high-quality ultrasonic images. In addition, key companies are launching new products to expand their endoscopy solutions portfolios. For instance, in January 2023, FUJIFILM India Private Limited launched ClutchCutter and FushKnife. These factors are expected to propel the market growth during the forecast period.

A rise in demand for minimally invasive procedures like EUS as they offer a faster recovery rate and minimize post-operative complications compared to traditional surgeries will support market growth. In addition, collaboration between medical device companies and healthcare institutions for R&D of EUS technologies further stimulates market growth. For instance, in September 2023, Fujifilm India formed a strategic partnership with the Yashoda Group of Hospitals. To improve patient care standards across the nation, this strategic alliance will support training and clinical research projects in collaboration with all Yashoda Group sites.

Endoscopic Ultrasound Market Report Highlights:

The endoscope segment led the market with the largest revenue share of about 33.84% in 2024.
Based on application, the lung cancer segment led the market with a 42.18% revenue share in 2024.
The hospital segment held the largest market share in 2024. This expansion is driven by favourable health reimbursement for minimally invasive procedures, well-developed healthcare infrastructure, and a growing number of skilled and qualified endoscopists.
The endoscopic ultrasound industry in North America dominated the global market and accounted for a revenue share of 31.0% in 2024.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Endoscopic Ultrasound Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Increasing prevalence of gastrointestinal cancer
  - 3.2.1.2. Growing geriatric population
  - 3.2.1.3. Rapid technological advancements
  - 3.2.1.4. Rise in demand for minimally invasive procedures
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Complications associated with endoscopic ultrasound imaging
3.3. Endoscopic Ultrasound Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Endoscopic Ultrasound Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Endoscopic Ultrasound Market Product Movement Analysis
4.3. Global Endoscopic Ultrasound Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Endoscope
- 4.4.1. Endoscope market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Ultrasound Probe
- 4.5.1. Ultrasound probe market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Needle
- 4.6.1. Needle market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Accessories
- 4.7.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Ultrasonic Processors
- 4.8.1. Ultrasonic processors market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Endoscopic Ultrasound Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Endoscopic Ultrasound Market Application Movement Analysis
5.3. Global Endoscopic Ultrasound Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Gastrointestinal Cancer
- 5.4.1. Gastrointestinal cancer market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Lung Cancer
- 5.5.1. Lung cancer market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Pancreaticobiliary Disease
- 5.6.1. Pancreaticobiliary disease market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Others
- 5.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Endoscopic Ultrasound Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Endoscopic Ultrasound Market End Use Movement Analysis
6.3. Global Endoscopic Ultrasound Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
- 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
- 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Endoscopic Ultrasound Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts, Trend Analysis, 2018 to 2030
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Competitive scenario
  - 7.4.1.3. Regulatory framework
  - 7.4.1.4. Reimbursement scenario
  - 7.4.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Competitive scenario
  - 7.4.2.3. Regulatory framework
  - 7.4.2.4. Reimbursement scenario
  - 7.4.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Competitive scenario
  - 7.4.3.3. Regulatory framework
  - 7.4.3.4. Reimbursement scenario
  - 7.4.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Europe
- 7.5.1. UK
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Competitive scenario
  - 7.5.1.3. Regulatory framework
  - 7.5.1.4. Reimbursement scenario
  - 7.5.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Germany
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Competitive scenario
  - 7.5.2.3. Regulatory framework
  - 7.5.2.4. Reimbursement scenario
  - 7.5.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. France
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Competitive scenario
  - 7.5.3.3. Regulatory framework
  - 7.5.3.4. Reimbursement scenario
  - 7.5.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Italy
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Competitive scenario
  - 7.5.4.3. Regulatory framework
  - 7.5.4.4. Reimbursement scenario
  - 7.5.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. Spain
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Competitive scenario
  - 7.5.5.3. Regulatory framework
  - 7.5.5.4. Reimbursement scenario
  - 7.5.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Norway
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Competitive scenario
  - 7.5.6.3. Regulatory framework
  - 7.5.6.4. Reimbursement scenario
  - 7.5.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Competitive scenario
  - 7.5.7.3. Regulatory framework
  - 7.5.7.4. Reimbursement scenario
  - 7.5.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.8. Denmark
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Competitive scenario
  - 7.5.8.3. Regulatory framework
  - 7.5.8.4. Reimbursement scenario
  - 7.5.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Japan
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Competitive scenario
  - 7.6.1.3. Regulatory framework
  - 7.6.1.4. Reimbursement scenario
  - 7.6.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. China
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Competitive scenario
  - 7.6.2.3. Regulatory framework
  - 7.6.2.4. Reimbursement scenario
  - 7.6.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. India
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Competitive scenario
  - 7.6.3.3. Regulatory framework
  - 7.6.3.4. Reimbursement scenario
  - 7.6.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Australia
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Competitive scenario
  - 7.6.4.3. Regulatory framework
  - 7.6.4.4. Reimbursement scenario
  - 7.6.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Competitive scenario
  - 7.6.5.3. Regulatory framework
  - 7.6.5.4. Reimbursement scenario
  - 7.6.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Competitive scenario
  - 7.6.6.3. Reimbursement scenario
  - 7.6.6.4. Regulatory framework
  - 7.6.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Latin America
- 7.7.1. Brazil
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Competitive scenario
  - 7.7.1.3. Regulatory framework
  - 7.7.1.4. Reimbursement scenario
  - 7.7.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Argentina
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Competitive scenario
  - 7.7.2.3. Regulatory framework
  - 7.7.2.4. Reimbursement scenario
  - 7.7.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.8. MEA
- 7.8.1. South Africa
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Competitive scenario
  - 7.8.1.3. Regulatory framework
  - 7.8.1.4. Reimbursement scenario
  - 7.8.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Competitive scenario
  - 7.8.2.3. Regulatory framework
  - 7.8.2.4. Reimbursement scenario
  - 7.8.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. UAE
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Competitive scenario
  - 7.8.3.3. Regulatory framework
  - 7.8.3.4. Reimbursement scenario
  - 7.8.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.4. Kuwait
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Competitive scenario
  - 7.8.4.3. Regulatory framework
  - 7.8.4.4. Reimbursement scenario
  - 7.8.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
- 8.4.1. Boston Scientific Corporation
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Medtronic
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. ConMed
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. Olympus Corporation
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Steris
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. SonoScape Medical Corp.
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. PENTEX Medical
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. FUJIFILM India Private Limited
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Cook Medical
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Medi-Globe GmbH
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

초음파 내시경 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Endoscopic Ultrasound Market Size, Share & Trends Analysis Report By Product (Needle, Endoscope), By Application (Gastrointestinal Cancer, Lung Cancer), By End Use (ASCs, Hospitals), By Region, And Segment Forecasts, 2025 - 2030

초음파 내시경 시장의 성장과 동향 :

초음파 내시경 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 초음파 내시경 시장의 변수, 동향, 범위

제4장 초음파 내시경 시장 : 제품 추정·동향 분석

제5장 초음파 내시경 시장 : 용도 추정·동향 분석

제6장 초음파 내시경 시장 : 최종 용도 추정·동향 분석

제7장 초음파 내시경 시장 : 지역 추정·동향 분석